WBC-60348-02351
2 vaccinations
1 coded response
6 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 945 / CA
- Registered
- 2021-06-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-06-02
Dose 1 — Pfizer-BioNTech
-
2021-06-11
Registered in v-safe
- 2021-06-11
-
2021-06-16
Survey response — day 14, dose 1MedDRA: Blood pressure increased, Chest discomfort, Dyspnoea, Headache — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11
-
2021-06-23
Dose 2 — Pfizer-BioNTech
- 2021-06-23
-
2021-06-30
Health check-in — day 7, dose 2Feeling: Poor · Site: Redness, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-07-07
- 2021-07-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-02 | Pfizer-BioNTech | |
| 2 | 2021-06-23 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood pressure increased | ✓ | ✓ | ✓ |
| SD | Chest discomfort | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release